Asthma trials in France

In France 46 Also abroad 500

46 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Where
Aix-en-Provence, Brest, Cholet, Le Chesnay, Le Kremlin-Bicêtre, Montfermeil, Paris, Pessac, Rennes, Suresnes
Age
18 years to 75 years
People
531 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07219173
Phase 4Taking people
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Where
Argenteuil Cedex, Brest, Cannes Cedex, Clamart, Créteil, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Lunel, Lyon Cedex 04, Marseille, Paris, Paris Cedex 18, Strasbourg Cedex, Toulouse
Age
6 years and over
People
2,500 worldwide
Run by
Sanofi
See details and how to joinNCT07556159 · EU 2025-524916-13-00
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Where
Brest, Le Kremlin-Bicêtre, Paris, Strasbourg
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07359846
Phase 2Taking people
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Where
Brest, Créteil, Lyon Cedex 04, Marseille, Pessac, Strasbourg Cedex, Suresnes
Age
18 years to 75 years
People
540 worldwide
Run by
AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00
No phaseTaking people
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
Where
Marseille
Age
18 years and over
People
448
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT06015256
Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Bron, Marseille, Montpellier, Nantes, Paris, Pessac, Suresnes
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 2Taking people
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Where
Dijon, Grenoble Cedex 9, Montpellier, Pessac, Saint-Herblain
Age
18 years to 75 years
People
600 worldwide
Run by
Windward Bio
See details and how to joinNCT07120503 · EU 2025-521391-58-00
No phaseTaking people
Towards Digital Management of Paediatric Asthma
Where
Paris
Age
4 years to 12 years
People
50
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06902766
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Strasbourg
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Brest, Bron, Créteil, Marseille, Paris, Rouen, Vandœuvre-lès-Nancy
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 4Taking people
Withdrawal of Dupilumab in Severe Asthma
Where
Amiens, Angers, Bayonne, Besançon, Bobigny, Brest, Caen Cedex 9, Cannes Cedex, Créteil, Dijon, Epagny Metz-tessy, Grenoble Cedex 9, Le Chesnay Rocquencourt, Le Kremlin-Bicetre, Le Mans Cedex 9, Lille Cedex, Lyon Cedex 04, Montivilliers, Nantes Cedex 01, Olivet, Paris Cedex 18, Pessac, Pierre-Bénite, Pontoise, Reims, Roubaix, Saint Pierre Cedex, Strasbourg, Suresnes, Tarbes Cedex 9, Toulouse, Tours
Age
18 years and over
People
205
Run by
University Hospital, Toulouse
See details and how to joinNCT06818019 · EU 2024-516789-13-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Amiens, Lyon Cedex 04, Montpellier, Paris Cedex 18, Pessac, Strasbourg Cedex, Toulouse
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseTaking people
Tezspire Cardiac Events PASS
Where
Paris
Age
12 years to 130 years
People
16,640 worldwide
Run by
AstraZeneca
See details and how to joinNCT06951867
No phaseTaking people
Forced Oscillations Technique During a Metacholine Test in Children
Where
Montpellier
Age
6 years to 16 years
People
112
Run by
University Hospital, Montpellier
See details and how to joinNCT05734261
Phase 3Taking people
ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
Where
Bron, Marseille, Montpellier Cedex 5, Nantes, Paris, Paris Cedex 18, Pessac, Suresnes
People
94 worldwide
Run by
AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00
Phase 2Taking people
A Study to Evaluate Brenipatide Compared with Placebo in Adult Participants with Uncontrolled Moderate to Severe Asthma
Where
Aix En Provence, Brest, Cholet, Le Chesnay Cedex, Le Kremlin-Bicetre, Montfermeil, Paris Cedex 18, Pessac, Rennes, Suresnes
Age
18 years to 64 years
People
137 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522640-41-00 · EU 2025-522640-41-00
No phaseNot yet taking people in France
Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE
Where
Pessac
Age
1 year to 80 years
People
650
Run by
University Hospital, Bordeaux
See details and how to joinNCT07780630
No phaseTaking people
Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department
Where
Poitiers
Age
18 years and over
People
60
Run by
Poitiers University Hospital
See details and how to joinNCT05691218
Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Aix En Provence, Brest, Brest Cedex 2, Cannes Cedex, Grenoble Cedex 9, Marseille, Paris, Strasbourg Cedex
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Créteil, Lille Cedex, Nice, Paris
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Brest, Le Chesnay Rocquencourt, Le Kremlin-Bicetre, Paris, Strasbourg Cedex
People
80 worldwide
Run by
Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 · EU 2025-524040-35-00
Phase 3Taking people
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Where
Marseille, Paris, Strasbourg Cedex, Toulouse Cedex 9
Age
Up to 17 years
People
68 worldwide
Run by
Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00
No phaseTaking people
Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study).
Where
Marseille
Age
18 years and over
People
195
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT07134686
Phase 4Taking people
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Where
Aix En Provence, Cannes Cedex, Cornebarrieu, Marseille, Paris, Strasbourg Cedex, Suresnes, Villeurbanne
Age
18 years and over
People
644 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00
Phase 3Taking people
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Where
Brest, Créteil, Grenoble Cedex 9, Montpellier Cedex 5, Pessac, Reims Cedex
Age
18 years and over
People
150 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00